The stock of Acutus Medical Inc (NASDAQ:AFIB) last traded at $0.25, up 32.90% from the previous session.
Data from the available sources indicates that Acutus Medical Inc (NASDAQ:AFIB) is covered by 1 analysts. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $0.50 and a low of $0.50, we find $0.50. Given the previous closing price of $0.19, this indicates a potential upside of 163.16 percent. AFIB stock price is now -55.80% away from the 50-day moving average and -69.64% away from the 200-day moving average. The market capitalization of the company currently stands at $7.21M.
In total, 1 analysts have assigned it a hold rating, and 0 have given it a buy rating. Brokers who have rated the stock have averaged $0.50 as their price target over the next twelve months.
Insiders disposed of 61,510 shares of company stock worth roughly $15377.5 over the past 1 year. A total of 36.71% of the company’s stock is owned by insiders.
With an opening price of $0.1810 on Friday morning, Acutus Medical Inc (NASDAQ: AFIB) set off the trading day. During the past 12 months, Acutus Medical Inc has had a low of $0.16 and a high of $1.96. As of last week, the company has a debt-to-equity ratio of 1.23, a current ratio of 4.92, and a quick ratio of 3.85. The fifty day moving average price for AFIB is $0.5522 and a two-hundred day moving average price translates $0.8029 for the stock.
The latest earnings results from Acutus Medical Inc (NASDAQ: AFIB) was released for Sep, 2023. According to the Medical Devices Company, earnings per share came in at -$0.45, beating analysts’ expectations of -$0.61 by 0.16. This compares to -$0.72 EPS in the same period last year. The net profit margin was -166.79% and return on equity was -73.28% for AFIB. The company reported revenue of $5.24 million for the quarter, compared to $3.64 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 43.74 percent. For the current quarter, analysts expect AFIB to generate $6.63M in revenue.
Acutus Medical Inc(AFIB) Company Profile
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. The company was incorporated in 2011 and is headquartered in Carlsbad, California.